Target intelligence / Profile preview

Human Immunodeficiency Virus 1 (HIV-1)

Target
HIV-1
Molecular classification
Retrovirus
01

Overview

Human immunodeficiency virus type 1 (HIV-1) is a retrovirus and the primary causative agent of acquired immunodeficiency syndrome (AIDS). It infects human immune cells, leading to progressive immune system failure. HIV-1 virions are approximately 100–120 nm in diameter and contain a lipid envelope with viral glycoproteins gp120 and gp41. Beneath the envelope lies the matrix protein p17, which surrounds a conical capsid made of p24 protein. The capsid encloses two copies of positive-sense single-stranded RNA (~9.7 kb each), tightly bound by nucleocapsid proteins p7 and p6. Also within the core: essential enzymes reverse transcriptase, integrase, and protease; accessory proteins Vif, Vpr, Nef; regulatory proteins Tat and Rev; unique HIV-1 protein Vpu.

02

Mechanism of action

Inhibition of viral replication through targeting viral enzymes or entry mechanisms.

03

Biological functions

Viral replicationImmune evasionCell entry
04

Disease associations

AIDSInfection
05

Safety considerations

Drug resistanceLong-term toxicity of antiviral therapiesImmune reconstitution inflammatory syndrome (IRIS)
06

Interacting drugs

Reverse transcriptase inhibitors

3 more in the full profile.

07

Biomarkers

Viral loadCD4 countDrug resistance mutations

Beyond the preview

Go deeper on Human Immunodeficiency Virus 1 (HIV-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Immunodeficiency Virus 1 (HIV-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call